top of page
iPharmaCenter
Global | Comprehensive | Patient Centric
Home
News
Regional News
North America
US FDA Approvals
US CMS News
US Payer News
Canada Drug Healthcare News
APAC
China - Drug Healthcare News
India - Drug Healthcare News
APAC - Drug Approvals
APAC - Healthcare News
Japan Drug Approvals | Healthcare
Europe
EMA News
Europe Healthcare News
Latam
Lacam - Drug approvals
Lacam Healthcare News
Healthcare Policies
Disease Information
Diseases
Disease News
Conferences
Others
COVID-19
Contact
Viber -Pharma and healthcare news on mobile
All Posts
Healthcare Systems
News
Conferences
Know your disease
COVID
Japan drug approvals
USA Pharma News | Healthcare News
Europe Pharma News
Japan drug approvals
Australia Pharma & Healthcare News
Canada Pharma and Healthcare News
Asia | Pharma | Healthcare News
Indication News
Latam
US FDA News
CMS News
India Drug Healthcare
China Drug Approvals
Europe Healthcare News
APAC Drug approvals
US_PayerNews
Australia TGA Approvals
Search
Log in / Sign up
ipharmaservices
Sep 7, 2020
FDA approved Roche’s Gavreto for RET fusion-positive NSCLC
bottom of page
